Genmab will stop development of its experimental antibody therapy to treat cancer that was in late-stage trials, the Danish ...

The discovery could pave the way for new treatments, improved risk prediction, and earlier intervention for brain metastases.

A team of cancer biologists led by Princeton’s Yibin Kang has resolved a confounding paradox about retinoids and cancer cells ...

The decision to end the programme comes 18 months after Genmab's former partner for the acasunlimab, BioNTech, pulled out of ...

Scientists at the Princeton University Branch of the Ludwig Institute for Cancer Research have identified novel mechanisms by ...

A protein once thought to simply help cancer cells avoid death turns out to do much more. MCL1 actively drives cancer ...

Cancer is becoming a global crisis shaped less by biology than by inequality, risk exposure, and access to care.

A new study reveals how a single cancer protein may simultaneously drive tumor survival and metabolic control, uncovering a ...

With enrollment completed and encouraging immune response and safety data observed in the Phase 1 trial, Anixa plans to advance the vaccine into a Phase 2 clinical trial and has assumed full ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. On the regional level, as the Human Development Index ...